Alembic Pharmaceuticals gets EIR from USFDA for Gujarat new Injectable facility

11 Oct 2021 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out at New Injectable Facility (F-3) at Karakhadi, Gujarat during the period from January 28, 2021 to February 06, 2021, indicating that the USFDA finds company’s responses to their observations to be adequate. USFDA has also indicated that compliance verification would be performed during re-inspection of the said Facility in the next review cycle. 

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Alembic Pharma Share Price

761.20 -9.65 (-1.25%)
24-Feb-2026 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1725.00
Dr. Reddys Lab 1313.50
Cipla 1323.05
Zydus Lifesciences 906.20
Lupin 2242.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×